论文部分内容阅读
为了观察抗胸腺淋巴细胞球蛋白（ＡＴＧ）的免疫抑制效果，将肾移植术后单独应用环孢素Ａ（ＣｓＡ）和术后早期小剂量应用ＡＴＧ的各２００例患者作了比较，结果ＣｓＡ组发生急性排斥反应（ＡＲ）４６例次（２３％），逆转４１例（８９．１％）；ＡＴＧ组发生ＡＲ３３例（１６．５％），逆转３１例（９３．９％）。肾功能在２～１０天恢复正常的，ＣｓＡ组为８４例（４２％），ＡＴＧ组为１５９例（７９．５％）；肾移植后合并感染，ＣｓＡ组３６例，ＡＴＧ组１８例；ＣｓＡ组摘肾８例，ＡＴＧ组４例；ＣｓＡ组死亡５例，ＡＴＧ组３例。本组资料提示小剂量ＡＴＧ的应用对延长肾移植后存活时间有重要意义
In order to observe the immunosuppressive effect of anti-thymus lymphocyte globulin (ATG), 200 patients who received cyclosporine A (CsA) alone and small early postoperative ATG after renal transplantation were compared. Results CsA group Acute rejection (AR) 46 cases (23%), reversal of 41 cases (89.1%); ATG group AR33 cases (16.5%), 31 cases of reversal (93.9%). Renal function returned to normal after 2 to 10 days, 84 cases (42%) in CsA group and 159 cases (79.5%) in ATG group, 36 cases in CsA group, 18 cases in ATG group and CsA 8 cases were kidneys from kidney and 4 cases from ATG. 5 cases died from CsA and 3 cases from ATG. The data suggest that the application of low-dose ATG to extend the survival time after renal transplantation is important